Pancreatic Cancer Action Network

KRAS and Pancreatic Cancer: Entering a New Era of Treatment

Join PanCAN on Thursday, June 25, at 11 a.m. PT / 2 p.m. ET, for a webinar focused on KRAS and pancreatic cancer. Our panel ...
pancan

In Conversation: John O’Grady, PurpleStride Chair, Hampton Roads Affiliate

Editor’s Note: Survivor and Hampton Roads PurpleStride Chair John O’Grady spoke with Community Engagement Senior Specialist Paula Mukherjee about his volunteer experiences and advice for others ...
pancan

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know

Details about an Expanded Access Program (EAP) for daraxonrasib are now available. The EAP is intended to provide daraxonrasib to eligible adult patients with previously treated metastatic pancreatic ...
pancan

Pancreatic Cancer Specialists and Centers

Seeing pancreatic cancer specialists improves outcomes. The Pancreatic Cancer Action Network strongly recommends consulting with pancreatic cancer specialists who have experience diagnosing and ...
pancan

Your Advocacy in Action: The Road to Increased Federal Research Funding

You sent messages and made calls. And now, the Senate Dear Colleague letter supporting renewed and sustained funding for dedicated pancreatic cancer research has officially closed, and we saw ...
pancan

Pancreatic Cancer Diagnoses and Mortality Rates Climb; Five-Year Survival Rate for Pancreatic Cancer Stalls at 13%

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...
pancan

Five-Year Pancreatic Cancer Survival Rate Increases to 12%

American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.
pancan

PanCAN’S Julie Fleshman Joins Leaders of National Patient Advocacy Organizations to Send a Powerful and Unified Message to Congress: “Cancer Research Is Not a Line Item. It ...

The administration’s fiscal year 2026 proposed budget included devastating cuts to the National Institutes of Health (NIH) and National Cancer Institute (NCI). In response, and as Congress returns to ...
pancan

New Paper Highlights Urgent Need for Pancreatic Cancer Progress

The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...
pancan

Pancreatic Cancer Action Network Calls for Immediate, Sustained Investment in Research Toward Early Detection and Treatment to Increase Survival

LOS ANGELES, Calif. – (January 13, 2026) – Pancreatic cancer remains the third-leading cause of cancer-related deaths in the United States, behind lung and colorectal cancers. According to the ...
pancan

17-Year Survivor: ‘I’m Here to Offer Hope’

Editor’s note: Kitty Swink is a 17-year pancreatic cancer survivor and “Star Trek: Deep Space Nine” actress. She is also a PanCAN Ambassador as part of our “Talk. Test. Take Control.” campaign that ...
pancan

What to Know About Pancreatic Enzymes

Pancreatic enzymes help to break down fats, proteins and carbohydrates, making them critical for digestion and the absorption of nutrients. Often, pancreatic tumors prevent the production of these ...